125 related articles for article (PubMed ID: 1728077)
21. Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination.
Papp KA; Breuer K; Meurer M; Ortonne JP; Potter PC; de Prost Y; Davidson MJ; Barbier N; Goertz HP; Paul C
J Am Acad Dermatol; 2005 Feb; 52(2):247-53. PubMed ID: 15692469
[TBL] [Abstract][Full Text] [Related]
22. [Immunogenicity and safety of a tetanus-diphtheria vaccine (adult type): clinical trial in adults].
Gil A; Dal-Ré R; González A; Lasheras L; Aguilar L; del Rey J
Med Clin (Barc); 1995 Feb; 104(4):126-9. PubMed ID: 7898155
[TBL] [Abstract][Full Text] [Related]
23. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections.
Mirchamsy H; Manhouri H; Hamedi M; Ahourai P; Fateh G; Hamzeloo Z
Biologicals; 1996 Dec; 24(4):343-50. PubMed ID: 9088551
[TBL] [Abstract][Full Text] [Related]
24. The immune response to booster vaccination against diphtheria toxin at age 18-21 years.
Nahum E; Lerman Y; Cohen D; Salpon R; Danon YL
Isr J Med Sci; 1994 Aug; 30(8):600-3. PubMed ID: 8045740
[TBL] [Abstract][Full Text] [Related]
25. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines.
West CE; Gothefors L; Granström M; Käyhty H; Hammarström ML; Hernell O
Pediatr Allergy Immunol; 2008 Feb; 19(1):53-60. PubMed ID: 18086218
[TBL] [Abstract][Full Text] [Related]
26. Antibody response after vaccination with tetanus and diphtheria toxoids in human T-cell lymphotropic virus type 1 asymptomatic carriers.
Biasutti C; Moraes-Pinto MI; Segurado AC
Vaccine; 2008 Jun; 26(23):2808-10. PubMed ID: 18455282
[No Abstract] [Full Text] [Related]
27. Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine.
Puumalainen T; Ekström N; Zeta-Capeding R; Ollgren J; Jousimies K; Lucero M; Nohynek H; Käyhty H
J Infect Dis; 2003 Jun; 187(11):1704-8. PubMed ID: 12751027
[TBL] [Abstract][Full Text] [Related]
28. Short-term booster effect of diphtheria toxoid in initially long-term protected individuals.
Danilova E; Shiryayev A; Skogen V; Kristoffersen EK; Sjursen H
Vaccine; 2005 Feb; 23(12):1446-50. PubMed ID: 15670879
[TBL] [Abstract][Full Text] [Related]
29. [Immunity against diphtheria and tetanus in the adult Polish population].
Walory J; Grzesiowski P; Hryniewicz W
Pol Merkur Lekarski; 2000 Oct; 9(52):687-92. PubMed ID: 11144058
[TBL] [Abstract][Full Text] [Related]
30. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
[TBL] [Abstract][Full Text] [Related]
31. Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination.
Krüger S; Seyfarth M; Sack K; Kreft B
Vaccine; 1999 Mar; 17(9-10):1145-50. PubMed ID: 10195626
[TBL] [Abstract][Full Text] [Related]
32. [A phase-I clinical trial of a new antitetanus/antidiphtheria vaccine for adults].
Podda A; Vescia N; Donati D; Marsili I; Volpini G; Nencioni L; Mastroeni I; Rappuoli R; Fara GM
Ann Ig; 1991; 3(2):79-84. PubMed ID: 1725595
[No Abstract] [Full Text] [Related]
33. Simultaneous vitamin A administration at routine immunization contact enhances antibody response to diphtheria vaccine in infants younger than six months.
Rahman MM; Mahalanabis D; Hossain S; Wahed MA; Alvarez JO; Siber GR; Thompson C; Santosham M; Fuchs GJ
J Nutr; 1999 Dec; 129(12):2192-5. PubMed ID: 10573548
[TBL] [Abstract][Full Text] [Related]
34. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.
Grandjean P; Andersen EW; Budtz-Jørgensen E; Nielsen F; Mølbak K; Weihe P; Heilmann C
JAMA; 2012 Jan; 307(4):391-7. PubMed ID: 22274686
[TBL] [Abstract][Full Text] [Related]
35. Serum antibody level in rabbits submitted to antitetanus active-passive immunization with heterologous horse serum.
Bistoni F; Marconi P; Bastianini L; Sbaraglia G; Pitzurra M
Boll Ist Sieroter Milan; 1978 Mar; 57(1):30-7. PubMed ID: 656195
[TBL] [Abstract][Full Text] [Related]
36. [Monthly dynamics of the antitoxic immunity against diphtheria and tetanus and of normal antibodies to fraction I of the plague microbe in adults].
Basova NN; Kravtsov FE; Naumovich LS
Zh Mikrobiol Epidemiol Immunobiol; 1982 Mar; (3):82-6. PubMed ID: 6211009
[TBL] [Abstract][Full Text] [Related]
37. Designed transfer of specific immune responses with bone marrow transplantation.
Saxon A; Mitsuyasu R; Stevens R; Champlin RE; Kimata H; Gale RP
J Clin Invest; 1986 Oct; 78(4):959-67. PubMed ID: 3531239
[TBL] [Abstract][Full Text] [Related]
38. Enhanced early response to tetanus toxoid, in rabbits.
Bistoni F; Marconi P; Mosci L; Vecchiarelli A; Pitzurra M
Boll Ist Sieroter Milan; 1977 Nov; 56(5):437-41. PubMed ID: 597395
[TBL] [Abstract][Full Text] [Related]
39. Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease.
Nielsen HJ; Mortensen T; Holten-Andersen M; Brünner N; Sørensen S; Rask-Madsen J
Scand J Gastroenterol; 2001 Mar; 36(3):265-9. PubMed ID: 11305513
[TBL] [Abstract][Full Text] [Related]
40. [Antibody response to tetanus and diphtheria toxoids in adult patients with solid neoplasms].
Marconi P; Bistoni F; Mosci L; Tissi L; Vecchiarelli A; Di Leo S; Dominici C; Pitzurra M
Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2264-70. PubMed ID: 754725
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
